South Korea · Delayed Price · Currency is KRW HK inno.N Company Description
HK inno.N Corporation engages in the pharmaceutical business in South Korea.
The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, non-small cell lung cancer, and mesothelioma, and colorectal cancer; and nutrition and intravenous nutrition.
It also provides health and beverage products, such as hangover relief, ready to drink, health supplements and health functional foods, as well as active pharmaceutical ingredients.
In addition, the company offers beauty products under the bewants, ScalpMed, and KLEDERMA RX brands. It also exports its products to Japan, Southeast Asia, Latin America, Europe, and the Middle East countries.
HK inno.N Corporation was founded in 1984 and is headquartered in Cheongju-si, South Korea.
| Country | South Korea |
| Founded | 1984 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,695 |
| CEO | Dal-Won Kwak |
Contact Details
Address: 239 Osongsaengmyeong 2-ro Cheongju-si, 28158 South Korea | |
| Phone | 82 4 3249 8800 |
| Website | inno-n.com |
Stock Details
| Ticker Symbol | 195940 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7195940002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dal-Won Kwak | Chief Executive Officer |